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Three new Ni(II) square planar complexes of 4-methoxy-3-benzyloxybenzaldehyde thiosemicarbazide(4m3BTSC) having
polypyridyl bases of general formulation [ML
2
] (1) and [MLB] (2, 3), where L = 4m3BTSC and B is N,N-donor heterocyclic bases,
namely, 1,10-phenanthroline (phen, 2), 2,2󸀠-bipyridine (bpy, 3), are synthesized and characterized.The free radical scavenging assay
results showed that complex 1 possesses significant activity when compared to complexes 2 and 3. The biological studies showed
that the ligand and its complexes exhibited significant and different biological activities and also the prepared compounds are
nonmutagenic. They may be potential commercial antioxidants because of their nonmutagenic and nontoxic nature. The DNA
interaction of the new complexes is evaluated by absorption, emission, andmelting temperature methods, and the results suggested
that the binding affinity of the complexes increases with the presence of planar ligand in the molecule. The nickel (II) complexes
with planar phenanthroline bases show moderate DNA binding and cleavage ability.
1. Introduction
Schiff bases have great importance in coordination chemistry
due to their ability to form a range of complexes with
applications in different fields [1]. Thiosemicarbazones have
variable bonding modes, ability to form stable chelates with
metal ions, and structural diversity [2]. The sulfur, oxygen,
and nitrogen may be involved in coordination providing a
useful model for bioinorganic processes [3]. These thiosemi-
carbazide ligands have good complexing ability, and their
activity increases on complexation with transition metal ions
[4]. These compounds are also of interest due to their biolog-
ical activities including enzyme inhibition [5] and antifungal
and pharmacological applications [6, 7]. The toxicological
importance of the –N–C=S moiety has been well established
in antifungal, antibacterial agents and pesticidal activities
[8, 9]. It has been suggested that the azomethine linkage in
Schiff bases is responsible for the biological activities such as
antitumor, antibacterial, antifungal, and herbicidal activities
[10].
The biological activities of thiosemicarbazones often
showed a high dependence on their substituents. Minor
modifications in the structure of thiosemicarbazones can
lead to widely different biological activities. The biological
properties of thiosemicarbazones are often modulated by
metal coordination. In some cases, the highest biological
activity is associated with a metal, and some side effects may
decrease upon complexation [11].
Nickel(II) complexes have found several potential appli-
cations in medicine, and very recently they have been
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screened for inhibition of cancer cell proliferation [12, 13].
In the last 20 years transition metal complexes have become
increasingly important as drugs and artificial nucleases.
One goal of designing Ni(II) complexes is developing more
reactive chemical systems that can efficiently cleave DNA
under physiological conditions [14–16].
Substantial progress has been made during the past few
decades to develop metal-based small molecules as DNA
foot-printing as well as the therapeutic agents that are capable
of binding and cleaving DNA under physiological condition
[17, 18]. Among the metal complexes so far investigated,
those of polypyridyl phenanthroline bases have attracted
great attention by virtue of its binding propensity to nucleic
acid under the physiological condition [19, 20].
In view of the varying ligation behavior and interesting
biological activity shown by these nitrogen-sulfur ligands
and their complexes, we are also interested to prepare
the thiosemicarbazide Schiff base and its metal complexes.
Designing of these metal complexes has been undertaken,
and their biological activities have been studied.The study of
biological activities of benzyloxy benzaldehyde-Schiff bases
is less explored. Herein, we present the syntheses, struc-
ture, antioxidant, antimicrobial, and mutagenic activities
and DNA interactions of nickel(II) complexes of general
formulae [Ni(L)
2
] (1), [Ni(L)(B)] (2, 3) where L is ligand
4m3BTSC (4-methoxy-3-benzyloxybenzaldehyde thiosemi-
carbazide) and B is N,N-donor heterocyclic base, namely,
1,10-phenanthroline (phen), 2,2󸀠-bipyridine (bpy).
2. Experimental
2.1. Materials and Instrumentation. All reagents and chemi-
cals were of AR grade and used as purchased.The 4-methoxy-
3-benzyloxy benzaldehyde, thiosemicarbazide, and various
metal salts were Merck products and used as supplied. The
agarose (molecular biology grade) and ethidium bromide
(EB) were obtained from Sigma. Calf thymus (CT) DNA
and Supercoiled (SC) pUC19 DNA (cesium chloride puri-
fied) were purchased from Bangalore Genie (India). The
tris(hydroxymethyl)-aminomethane-HCl (tris-HCl) buffer
was prepared by doubly distilled H
2
O.
Bacterial Strains. The four Salmonella typhimurium mutant
strains (histidine-dependant) TA98, TA100, TA1535, and
TA1538 were procured from IMTECH, Chandigarh, India.
For mutagenicity assay, each bacterial culture was inoculated
in 10mL of fresh nutrient broth and incubated at 37∘C for
14 h. All chemicals and bacterial media were purchased from
Himedia.
The elemental analyses were carried out by using vario-
micro CHNS15106062 analyzer. 1HNMR and ESI-MS data of
the compounds were recorded at the Sophisticated Analytical
and Instrument Facility, IISc, Bangalore. The IR spectra of
the samples were recorded on a Shimadzu spectrophotometer
from 4000 to 400 cm−1 using KBr pellets. The UV-Vis spec-
tra were recorded on a Shimadzu UV-3101PC spectropho-
tometer using DMF as solvent. The molar conductances of
the complexes were measured using Equiptronics digital
conductivitymeter number EQ-660A, and themelting points
were checked bymelting point apparatus used in laboratories.
Magnetic susceptibility data at 300K for the polycrystalline
samples of the complexes were obtained byVSM, IITMadras.
2.2. Synthesis. The Schiff base ligand 4m3BTSC was synthe-
sized by reported procedure [21].
2.2.1. Preparation of [Ni(L)
2
](X) (1) (L = 4m3BTSC, X =DMF)
and [Ni(L)(B)] (2, 3) (B = phen, bpy) Complexes. The com-
plexes were prepared by following a modified reported [22]
synthetic procedure in which a 10mL methanolic solution
of Ni(CH
3
COO)
2
⋅4H
2
O (0.24 g, 1mmol) was reacted with
4m3BTSC (0.315 g, 1mmol) in acetonitrile (10mL) under
magnetic stirring at room temperature.The resulting precipi-
tate was filtered off, washedwithmethanol, and air-dried.The
obtained precipitate was dissolved in dimethyl formamide
and leaving it to stand for a week on slow evaporation
of the solution at room temperature yielded a crystalline
material (1). Crystals of complexes were suitable for X-ray
diffraction studies. After 30min, a 20mLmethanolic solution
of the heterocyclic base [phen (0.198 g, 1mmol) bpy (0.156 g,
1mmol)] was added to the solution, and the resultingmixture
was stirred for 2 h at room temperature. On cooling the
solution to an ambient temperature, it was filtered and the
filtrate on slow concentration yielded a crystalline solid of
the product (2, 3). The solid was isolated and washed with
cold methanol and finally dried over P
4
O
10
. The FT-IR, 1H
NMR and ESI-MS spectras for all the complexes are given in
supplementary material (Figures S1–S9).
Analyses Calculaed for Complex 1 (C
32
H
34
N
6
NiO
4
S
2
). CHNS
Analyses Calc: C, 55.74; H, 4.99; N, 12.19; S, 9.60; found: C,
53.13; H, 5.05; N, 13.03; S, 9.43%. FT-IR; cm−1, (KBr disc):
3420m (NH
2
), 3180m (N–H), 1596 s (C=N), 1522m (C=C),
1020m (–N–N), 800m (C=S), 466m (Ni–N), cm−1, for
complex 1: 𝜆max /nm (𝜀/dm3M−1 cm−1) in DMF: 532(490),
438(580), 370(1600), 340(2220), 285(1230), 268(23833), 𝜇eff
(solid, 300K): 0.41 𝜇B, ΛM (Ω
−1 cm2M−1) in DMF at 25∘C:
11.7, ESI-MS; 688.01.
Analyses Calculaed for Complex 2 (C
28
H
25
N
5
NiO
2
S). CHNS
Analyses, Calc: C, 60.67; H, 4.55; N, 12.63; S, 5.79; found:
C, 61.32; H, 4.88; N, 12.82, S, 5.81%. FT-IR; cm−1, (KBr
disc): 3420m (NH
2
), 3180m (N–H), 1600 s (C=N), 1522m
(C=C), 1020m (–N–N), 817m (C=S), 455m (Ni–N), cm−1,
𝜆max/nm (𝜀/dm
3M−1 cm−1) in DMF: 530(470), 434(700),
370(1550), 338(2520), 272(2530). (solid, 300K): 0.30 𝜇B, ΛM
(Ω−1 cm2M−1) in DMF at 25∘C: 9.2, ESI-MS; 553.7.
Analyses Calculaed for Complex 3 (C
26
H
25
N
5
NiO
2
S). CHNS
Analyses, Calc: C, 58.89; H, 4.75; N, 13.21; S, 6.05; found:
C, 59.01; H, 4.96; N, 13.22, S, 6.31%. FT-IR; cm−1, (KBr
disc): 3420m (NH
2
), 3180m (N–H), 1600 s (C=N), 1522m
(C=C), 1020m (–N–N), 810m (C=S), 455m (Ni–N), cm−1,
𝜆max/nm (𝜀/dm
3M−1 cm−1) in DMF: 528(530), 435(860),
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375(2260), 338(2870), 268(2450), 𝜇eff (solid, 300K): 0.40 𝜇B,
ΛM (Ω
−1 cm2M−1) in DMF at 25∘C: 8.4, ESI-MS; 529.6.
2.3. X-Ray Crystallographic Procedures. Single crystal of the
complex 1 was grown by slow evaporation of DMF solution.
Darkgrey single crystal was mounted on a glass fiber with
epoxy cement. The X-ray diffraction data were measured in
frames with increasing 𝜔 (width of 0.3∘ per frame) and with
a scan speed at 15 s/frame on a Bruker SMART APEX CCD
diffractometer, equippedwith a fine focus 1.75 kWsealed tube
X-ray source. Empirical absorption corrections were carried
out using multiscan program [23]. The structure was solved
by the heavy atom method and refined by full matrix least-
squares using SHELX system of programs [24].
2.4. Antioxidant Activity
2.4.1. 2,2-Diphenyl-1-picryl-hydrazyl (𝐷𝑃𝑃𝐻∙) Radical Scav-
enging Method. The reduction capability of DPPH radicals
was determined by the decrease in its absorbance at 517 nm
which can be induced by antioxidants [25]. Antioxidant
activity of ligand andmetal complexes was determined by the
method described by Brand-Williams et al. [26].The complex
solutions (100𝜇L, 1mmol) were mixed with 0.8mL of tris-
HCl buffer (pH 7.4) to which 1mL of DPPH∙ (500𝜇M in
ethanol) was added. The mixture was shaken vigorously and
left to stand for 30min. Absorbance of the resulting solution
was measured at 517 nm in a Uv-Vis Spectrophotometer.
The radical scavenging activity was measured by decrease in
the absorbance of DPPH. Lower absorbance of the reaction
mixture indicated higher free radical scavenging activity.
2.5. Antimicrobial Activity. The antibacterial activity was
tested against clinical isolates like Bacillus subtilis, Micro-
coccus luteus, Staphylococcus aureus, Klebsiella pneumoniae,
Escherichia coli, andPseudomonas aeruginosa.The test organ-
ismsweremaintained on nutrient agar slants. In vitro antibac-
terial activity was determined by the agar well-diffusion
method as described by Mukherjee et al. [27]. The overnight
bacterial culture was centrifuged at 8000 rpm for 10min.The
bacterial cells were suspended in saline to make a suspension
of 105 CFU/mL and used for the assay. Plating was carried out
by transferring the bacterial suspension to a sterile Petri plate
and mixed with molten nutrient agar medium, allowing the
mixture to solidify. About 75𝜇L of the sample (2mg/mL) was
placed in the wells. Plates were incubated at 37∘C, and activity
was determined by measuring the diameter of the inhibition
zones. The assay was carried out in triplicate.
2.6. Mutagenicity Assay. Mutagenicity of compounds was
studied by the preincubation assay as described by Maron
and Ames [28]. 100𝜇L of fresh culture of Salmonella strains
was treated with test compounds dissolved in DMSO with
concentrations of 2, 5, and 10mg/plate at 37∘C. For the
mutagenicity assay, the controls and compound-treated cells
were mixed with 2mL of sterile top agar and poured onto
minimal glucose agar plate.The plates were then inverted and
incubated at 37∘C for 48 hrs. Revertant colonies of bacteria
were countedmanually after 48 h. Each experiment consisted
of three replicates for each concentration.
2.7. DNA Binding Experiments. The UV absorbance at 260
and 280 nm of the CT-DNA solution in 5mM tris-HCl buffer
(pH 7.2) gave a ratio of 1.9, indicating that the DNA was free
of protein [29]. The concentration of CT DNA was measured
from the band intensity at 260 nm with a known 𝜀 value
(6600M−1 cm−1) [30]. Absorption titration measurements
were done by varying the concentration of CT DNA, keeping
the metal complex concentration constant in 5mM tris-
HCl/5mM NaCl buffer (pH 7.2). Samples were kept for
equilibrium before recording each spectrum. The intrinsic
binding constant (𝐾
𝑏
) for the interaction of the complexes
with CT-DNAwas determined from a plot of [DNA]/(𝜀
𝑎
−𝜀
𝑓
)
versus [DNA] using absorption spectral titration data and the
following equation:
[DNA]
(𝜀
𝑎
− 𝜀
𝑓
)
=
[DNA]
(𝜀
𝑏
− 𝜀
𝑓
)
+ [K
𝑏
(𝜀
𝑏
− 𝜀
𝑓
)]
−1
, (1)
where [DNA] is the concentration of DNA in base pairs. The
apparent absorption coefficients 𝜀
𝑎
, 𝜀
𝑓
, and 𝜀
𝑏
correspond to
𝐴obsd./[Ni], the extinction coefficient for the free nickel(II)
complex, and extinction coefficient for the nickel(II) complex
in the fully bound form, respectively [31]. 𝐾
𝑏
is given by the
ratio of the slope to the intercept.
The apparent binding constant (𝐾app) of the complexes
was determined by fluorescence spectral technique using
ethidium bromide (EB) bound CT DNA solution in tris-
HCl/NaCl buffer (pH 7.2). The fluorescence intensities of EB
at 600 nm (546 nm excitation) with an increasing amount of
the ternary complex concentration were recorded. Ethidium
bromide was nonemissive in tris-buffer medium due to fluo-
rescence quenching of the free EB by the solvent molecules
[32, 33]. In the presence of DNA, EB showed enhanced
emission intensity due to its intercalative binding to DNA.
A competitive binding of the copper complexes to CT DNA
could result in the displacement of EB or quenching of the
bound EB by the paramagnetic nickel(II) species decreasing
its emission intensity.
DNA-melting experiments were carried out by moni-
toring the absorbance of CT-DNA (200𝜇M NP) at 260 nm
with varying temperature in the absence and presence of the
complexes in 2 : 1 ratio of DNA to complex with a ramp rate
of 0.5∘Cmin−1 in phosphate buffer (pH 6.85) using a Peltier
system attached to the UV-Vis spectrophotometer.
2.8. DNA Cleavage. The extent of cleavage of supercoiled
(SC) DNA in the presence of the complex and oxidizing
agent H
2
O
2
was determined by agarose gel electrophoresis.
In a typical reaction, supercoiled pUC19 DNA (0.2𝜇g), taken
in 50mM tris-HCl buffer (pH 7.2) containing 50mM NaCl,
was treated with the complex. The extent of cleavage was
measured from the intensities of the bands using UVITEC
Gel Documentation System. For mechanistic investigations,
inhibition reactions were done on adding the reagents prior
to the addition of the complex. The solutions were incubated
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Table 1: Analytical and physical data of the ligand and its complexes.
Complex 1 2 3
Colour, aMP/∘C Dark brown, 190 Cream, 195 Cream, 195
bIR (cm−1)/](C=N) + ](C=S) 1596, 800 1600, 817 1600, 810
cd-d band (nm) 532 530 530
d
ΛM/Ω
−1cm2mol−1 11.7 9.2 8.4
e
𝜇eff 0.3 0.4 0.4
aMelting point, bKBr Phase, cin DMF medium, din DMF medium at 25∘C, and e𝜇eff for solid at 300K.
for 1 h in a dark chamber at 37∘C followed by addition to
the loading buffer containing 25% bromophenol blue, 0.25%
xylene cyanol, and 30% glycerol (2 𝜇L), and the solution
was finally loaded on 0.8% agarose gel containing 1.0 𝜇g/mL
ethidium bromide (EB). Electrophoresis was carried out for
2 h at 60V in tris-acetate-EDTA (TAE) buffer. Bands were
visualized by UV light and photographed for analysis. Due
corrections were made to the observed intensities for the low
level of NC form present in the original sample of SC DNA
and for the low affinity of EB binding to SC in comparison to
nicked-circular (NC) and linear forms of DNA [34].
3. Results and Discussion
3.1. Synthesis and General Aspects. The new nickel(II) com-
plexes are prepared in high yield from the reaction of
Ni(CH
3
COO)
2
⋅4H
2
O with ligand 4m3BTSC and hetero-
cyclic bases. The complexes were soluble in DMF, DMSO
and sparingly soluble in acetonitrile, chloroform, and
dichloromethane. The analytical data correspond well with
the general formula [ML
2
] (DMF) (1) or [MLB], where M
is nickel, L = 4m3BTSC, and B is 1,10-phen, 2,2-bpy (2, 3).
The proposed structures of complexes 2 and 3 are given in
Figure 1. The molar conductance values of 1mM solutions of
the metal complexes in DMF at room temperature are in the
range of 8–12Ω−1cm2mol−1, indicating their nonelectrolytic
nature [35]. They are characterized from the analytical and
physicochemical data (Table 1). The complexes 2 and 3
display an intense charge transfer (CT) band in the range
200–310 nm,which can be attributed to the𝜋 → 𝜋∗ transition
of the coordinated N,N-donor heterocyclic base. The band
around 330 and 340 nm in all the complexes is due to
the imine (–HC=N–) and C=S groups, and the occurrence
of two d-d bands in the regions 527–538 and 430–438 nm
(1A
1
g→1B
2
g and 1A
1
g→1B
1
g transitions) is consistent with
a square planar structure for all the all complexes.
3.2. Crystal Structure of 1. The Ni(L)
2
(DMF) complex is
structurally characterized using single-crystal X-ray diffrac-
tion technique.The ORTEP diagram and numbering scheme
for Ni(L)
2
are shown in Figure 2. Crystallographic data
for complex 1 is presented in Table 2. X-ray studies reveal
that the complex has square planar geometry as is evident
from their bond parameters and bond angles (Table 3).
Complex 1 crystallizes in the centrosymmetric P2
1
/n space
group of the monoclinic crystal system with cell parameters,
𝑎 = 15.669(5) A˚, 𝑏 = 9.127(5) A˚, 𝑐 = 16.227(5) A˚, and
Table 2: Crystallographic data for NiL2(1) complex.
Formula C32H24N6NiO4S2
Formula weight 688.40
Crystal system, space group Monoclinic, P2
1
/𝑛
𝑎, 𝑏, 𝑐(A˚) 15.669(5), 9.127(5), 16.227(5)
𝛼
∘, 𝛽∘, 𝛾∘ 90, 116.2(5), 90
𝑉 (A˚3), 𝑍 2081.4(15), 4
𝑇 (K) 293
𝜃 23.8∘
𝜇 1.20mm−1
𝜆 (A˚) (MoK𝛼) 0.71073
𝐷
𝑥
2.168Mgm−3
Refinement method Full-matrix least-squares on 𝐹2
Goodness of fit on 𝐹2 1.07
𝑅int 0.027
Final 𝑅 indices 𝑤𝑅(𝐹2) = 0.134
Table 3: Selected bond lengths (A˚) and bond angles (∘) for NiL2(1)
complex.
Ni1–N1i 1.937(2) N1–N2 1.386(3)
Ni1–N1 1.937(2) N2–C16 1.295(4)
Ni1–S1 2.1614(11) N3–C16 1.335(4)
Ni1–S1i 2.1614(11) N4–C19 1.323(7)
S1–C16 1.716(3) N4–C18 1.384(7)
N1i–Ni1–N1 180.00(9) C18–N4–C17 122.0(7)
N1i–Ni1–S1 94.26(8) O1–C6–C7 108.3(3)
N1–Ni1–S1 85.74(8) O1–C8–C9 124.7(3)
N1i–Ni1–S1i 85.74(8) O1–C8–C13 114.6(3)
N1–Ni1–S1i 94.26(8) C9–C8–C13 120.7(3)
S1–Ni1–S1i 180.00(4) C8–C9–C10 120.3(3)
C16–S1–Ni1 97.15(11) O2–C13–C12 125.4(3)
C8–O1–C6 117.2(2) O2–C13–C8 115.0(3)
C13–O2–C14 118.0(2) C12–C13–C8 119.5(3)
C15–N1–N2 114.2(2) N1–C15–C10 133.4(3)
C15–N1–Ni1 125.8(2) N2–C16–N3 119.6(3)
N2–N1–Ni1 119.96(19) N2–C16–S1 122.8(2)
C16–N2–N1 113.9(2) N3–C16–S1 117.6(2)
C19–N4–C18 119.3(7) O2–C13–C12 125.4(3)
C19–N4–C17 118.7(5) O2–C13–C8 115.0(3)
𝑉 = 2081.4(15) A˚3. All nonhydrogen atoms were refined
anisotropically, and the hydrogen was refined isotropically.
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Figure 1: Proposed structures of Ni(II) complexes 2 and 3.
Figure 2: The ORTEP and ball and stick view of the complex Ni(L)
2
(DMF) (1).
The hydrogen atoms attached to the heteroatoms were in
their calculated positions and refined according to the riding
model. The coordination polyhedron around the nickel atom
is best described as square planar with an N
2
S
2
donor set.
The nickel atom is located at the centre of symmetry and
is coordinated by two sulphur atoms and two azomethine
nitrogen atoms from two Schiff base ligands in usual trans
arrangement.The trans bond angle ofN(1)–Ni–N(1) is exactly
180∘, and the bond angle between S(1)–Ni–S(1) is also 180∘,
this confirms that structure is square planar. The crystal
packing viewed along the cell axis displays nine independent
molecules accommodated in the crystallographic asymmet-
ric unit in which eight molecules occupy eight corners of the
unit cell and one more molecule is occupied in the centre of
the unit cell. The structure shows extensive intermolecular
noncovalent interactions, and it is also stabilized byN–H⋅ ⋅ ⋅O
intermolecular hydrogen bonding. Here the atom N3 acts as
a donor to O atom of the lattice DMF molecule (distance:
2.678 A˚). The unit cell packing diagram present in complex
1 is shown in Figure 3(a), and the intermolecular hydrogen
bonding is shown in Figure 3(b).
3.3. IR Spectra. In principle, the ligand can exhibit thione-
thiol tautomerism since it contains a thioamide –NH–C=S
functional group. The ](S–H) band at 2565 cm−1 is absent in
the IR spectrum of ligand, but ](N–H) band at ∼3265 cm−1 is
present, indicating that in the solid state the ligand remains
as the thione tautomer. The position of ](C=N) band of the
thiosemicarbazone appeared at 1616 cm−1 is shifted towards
lower wave number in the complexes indicating coordination
via the azomethine nitrogen. This is also confirmed by
the appearance of band in complexes in the range of 450–
455 cm−1, which has been assigned to the ](M–N) [36]. A
medium band found at 1014 cm−1 is due to the ](N–N) group
of the thiosemicarbazone.The position of this band is shifted
towards higher wave number in the spectra of complexes.
It is due to the increase in the bond strength, which again
confirms the coordination via the azomethine nitrogen. The
band appearing at ∼830 cm−1 corresponding to ](C=S) in the
IR spectrum of ligand is shifted towards lower wave number.
It indicates that thione sulfur coordinates to the metal ion
[37]. Thus, it may be concluded that the ligand behaves as
bidentate chelating agent coordinating through azomethine
nitrogen and thiolate sulfur.TheC–H stretching and bending
vibrations appear at 2780–2890 cm−1 and 1460–1420 cm−1,
respectively.
3.4. 1H NMR Spectra. The 1H NMR spectra of ligand and
its nickel complexes were recorded in CDCl
3
. The 1H NMR
spectrum of 4m3BTSC shows signal at 8.30 𝛿 indicating the
presence of azomethine (HC=N) proton. The singlet peaks
between 9.3–10.1 𝛿 and ∼6.8 𝛿 are assigned for the presence
of NH and NH
2
protons; however the multiplet in the region
7.10–7.6 𝛿 indicates the presence of the phenolic protons. No
signals are observed in the range 11.3-11.4 𝛿 which indicates
the absence of thiol (–SH) group. The other important
bands were observed at ∼3.9 𝛿 assigned for methyl (O–CH
3
)
protons and 5.16 𝛿 assigned for methylene (O–CH
2
) protons.
The azomethine proton in the Ni(II) complexes is shifted
downfield compared to free ligand, suggesting deshielding
of the azomethine group due to coordination with nickel.
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(a) (b)
Figure 3: (a) Molecular packing for the complex NiL
2
, viewed down the c-axis; (b) dashed lines indicate hydrogen bonds.
Table 4: 1H NMR spectra of ligand and its complexes.
Compounds –NH (𝛿) –CH=N– (𝛿) –Ph– (𝛿) –NH2 (𝛿) –CH2, –OCH3 (𝛿)
4m3BTSC 10.07 (s, 1H, NH) 8.30 (s, 1H) 7.1–7.4 (m) 8.02 (s, 2H, NH2)
5.16 (s, 2H, CH2)
3.90 (s, 3H, CH3)
1 10.1 (s, 1H, NH) 7.81 (s, 1H) 7.2–7.4 (m) 6.88 (s, 2H, NH2)
5.16 (s, 2H, CH2)
3.90 (s, 3H, CH3)
2 8.9 (s, 1H, NH) 7.97 (s, 1H) 7.2–7.4 (m) 6.82 (s, 2H, NH2)
5.16 (s, 2H, CH2)
3.90 (s, 3H, CH3)
3 8.9 (s, 1H, NH) 7.64 (s, 1H) 7.2–7.4 (m) 6.88 (s, 2H, NH2)
5.16 (s, 2H, CH2)
3.90 (s, 3H, CH3)
s: singlet and m: multiplet.
Table 5: DPPH radical scavenging activity of complexes 1, 2, and 3
and standards.
Compounds Conc. (𝜇M) aEC50
bARP cAE
4m3BTSC — NI NI NI
1 40 0.110 6.2 3.47 × 10−3
2 50 0.110 5.0 2.7 × 10−3
3 50 0.105 5.2 2.9 × 10−3
Vit-C 42 0.168 8.3 4.6 × 10−3
BHT 20 0.08 12.5 6.9 × 10−3
NI: no inhibition, aEC50: effective concentration = 𝜇M conc. of antioxi-
dant/𝜇M conc. of DPPH.
bARP: antioxidant radical power = 1/EC50.
cAE: antioxidant efficiency = 1/EC50 𝑇EC50 .
Vit-C: vitamin C.
BHT: butylated hydroxy anisole.
There is no appreciable change in the other signals of the
complexes (Table 4).
3.5. Antioxidant Activity
3.5.1. DPPH Radical Scavenging Activity. Various researchers
have used scavenging effect of a chemical on DPPH radical as
a quick and reliable parameter to assess the in vitro antioxi-
dant activity.The efficient concentration of complex required
to scavenge 50% of DPPH, EC
50
, is shown in Table 5. The
lower the EC
50
is, the better its radical scavenging activity is.
It is evident from results that free radical scavenging activities
of these compounds were concentration dependent. Among
the examined compounds, the complex 1 showed a strong
interactive ability with DPPH, expressed as EC
50
value of
40 𝜇Mconcentration, which was close to that of ascorbic acid
(30 𝜇M). Maximum free radical scavenging activity (56.9%)
was found in complex 1 followed by complex 3 (52.41%) and
complex 2 (51.8%), while least activity (32.88%) was observed
for free ligand 4m3BTSC. The comparative time-dependent
antioxidant activity of compounds and standards were shown
by graph in Figure 4. Antiradical efficiency (AE) involves the
potency (1/EC
50
) and the reaction time (𝑇EC
50
). The AE of all
the complexes are in the range of 2.5–3.5× 10−3, the value near
to standards and the complexes are good antioxidants [38].
3.6. Antibacterial Activity. The in vitro antibacterial activity
of the Schiff bases and their Ni(II) complexes were evaluated
against three Gram positive, S. aureus, B. subtilis, and M.
luteus, and three Gram negative bacteria, P. aeruginosa,
K. pneumoniae, and E. coli. Table 6 illustrates the antimi-
crobial activity of the synthesized compounds. In general,
the synthesized Schiff bases have more antibacterial activity
compared to their metal complexes; this may be due to
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Table 6:The values of zone inhibition (mm) of microorganisms for
the 4m3BTSC and its complexes 1, 2, and 3.
Bacteria 4m3BTSC 1 2 3
E. coli
(MTCC 443) 10 10 12 —
P. aeruginosa
(MTCC 741) — — 11 —
K. pneumonia
(MTCC 109) 12 — 14 10
B. subtilis
(MTCC 441) 12 10 15 9
M. luteus
(MTCC 106) 11 — 12 —
S. aureus
(MTCC 3160) — — 12 —
the greater liphophilic nature of the Schiff bases than their
metal complexes. The results showed that the complex 2
exhibited antibacterial activity against all the tested organ-
isms, namely, E. coli, P. aeruginosa, K. pneumoniae, B. subtilis,
M. luteus, and S. aureus. The result also indicated that the
complex 1 exhibited antibacterial activity against E. coli and
B. subtilis and that complex 3 exhibited antibacterial activities
against K. pneumonia and B. subtilis, respectively.The factors
that govern antimicrobial activities are strongly dependent
on the central metal ion and coordination numbers and are
also due to the presence of nitrogen and sulfur donor groups
[39, 40].
3.7. Mutagenic Assay. Themutagenic activity was carried out
by Ames test. The results indicate that all the complexes
are nonmutagenic in nature under assay condition. Accord-
ing to the Ames test, the tested ligand and its complexes
did not show mutagenicity with bacterial strain Salmonella
typhimurium types TA 98, TA 100, TA 1535, and TA 1538 in
the assayed range.
3.8. DNA Binding Properties. It was reported that DNA
bindingmode and affinity are affected by a number of factors,
such as planarity of ligands [41], the coordination geometry,
the ligand donor atom type [42], the metal ion type, and its
flexible valence [43]. The UV binding of the complexes 1–3
to the calf thymus (CT) DNA has been studied by electronic
absorption spectral technique.
The intrinsic binding constant (𝐾
𝑏
) value was 3.99(±0.04)
× 106M−1 for complex 2 (Figure 5).The complexes 1 and 3 did
not show binding affinity to CT-DNA due to lack of planarity.
The experimental values of𝐾
𝑏
revealed that complex 2 binds
to DNA via intercalative mode, and this may be due to the
presence of the phenanthroline ring in the structure.
The emission spectral method is used to study the relative
binding of the complexes to CT-DNA.The emission intensity
of ethidium bromide (EB) is used as a spectral probe. EB
shows reduced emission intensity in buffer solution because
of solvent quenching and an enhancement of the emission
intensity when intercalatively bound to DNA.The binding of
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Figure 4: The comparative time-dependent antioxidant activity of
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Figure 5: (a) Absorption spectral traces showing the decrease in
absorption intensity on gradual addition of CT-DNA (270𝜇M) in
aliquots to the solution of complex 2 (60𝜇M) in 5mM tris-HCl
buffer (pH 7.2) at 25∘C (shown by arrow). (b) Inset shows plot of
[DNA]/(𝜀
𝑎
− 𝜀
𝑓
) versus [DNA] for absorption titration of CT-DNA
with complex 2.
the complexes to DNA decreases the emission intensity of EB
(Figures 6(a), 6(b), and 6(c)).The relative binding propensity
of the complexes to DNA is measured from the extent of
reduction in the emission intensity (Figure 7). The apparent
binding constant (𝐾app) values for 1, 2, and 3 are given in
Table 7. The phen complex showed significantly higher 𝐾app
values than those of the bpy and bis ligand complexes.The bis
ligand complex is a poor binder to DNA.
The nature of the binding of the complexes to CT-
DNA was further investigated by DNA melting experiment.
Thermal behavior of the DNA in the presence of metal
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Figure 6:The emission spectral changes on addition of complexes 1 (a), 2 (b), and 3 (c) to the CT-DNA bound to ethidium bromide (shown
by arrow).
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Figure 7: The effect of addition of metal complexes 1, 2, and 3 to
the emission intensity CT-DNAbound ethidium bromide in a 5mM
tris-HCl (pH = 7.2) at 25∘C.
complexes can give insight into their conformational changes
and information about the interaction strength with DNA.
DNAmelting is observed when dsDNAmolecules are heated
Table 7: Intrinsic binding, apparent DNA binding, and melting
temperature studies.
Complexes a𝐾
𝑏
/M−1 b𝐾app/M−1 cΔ𝑇𝑚∘C
1 1.7 × 105 ⋅ ⋅ ⋅
2 3.99 × 106 10.98 × 105 +0.8
3 3.19 × 105 −0.4
aIntrinsic binding constant from absorption spectral method.
bApparent binding constant from competitive binding assay by emission
method.
cChanges in melting temperature of CT-DNA.
and separated into two single strands; it occurs due to
a disruption of the intermolecular forces, such as 𝜋 stacking
andhydrogen bonding interactions, betweenDNAbase pairs.
A classical intercalator such as EB stabilizes the duplex
DNA, causing the DNA to melt at a higher temperature [44].
The melting temperature of CT-DNA in the absence of any
added complex was found to be 65.5∘C in our experimental
conditions. Under the same set of conditions, in the presence
of all the complexes, they gaveΔ𝑇
𝑚
values ranging from0.4 to
+0.8∘C indicating primarily DNA groove binding propensity
of the complexes. The phen complex 2 with a relatively
high Δ𝑇
𝑚
value of +0.8∘C could have a partial intercalative
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Table 8: Selected cleavage data of SC pUC19 by ligand and its
complexes 1, 2, and 3.
Lane no. Conditions [Complex] 𝜇M aSC% bNC%
1 DNA control — 97 3
2 DNA + Ligand + H2O2 60 92 8
3 DNA + Ligand + MPA 60 93 7
4 DNA + 1 + MPA 60 90 10
5 DNA + 2 + MPA 60 87 13
6 DNA + 3 + MPA 60 89 11
7 DNA + 1 + H2O2 60 78 22
8 DNA + 2 + H2O2 60 65 35
9 DNA + 3 + H2O2 60 75 25
aSC: supercoiled DNA.
bNC: nicked circular DNA.
mode of DNA binding with the planar ring of 1,10-phen
intercalating to the DNA base pairs.
3.9. DNA Cleavage Studies. The oxidative DNA cleavage
activity of the complexes in the presence of oxidizing agent
hydrogen peroxide (H
2
O
2
, 50mM) is investigated by agarose
gel electrophoresis using supercoiled (SC) plasmid pUC19
DNA (0.2𝜇g, 33.3 𝜇M NP) in 50mM tris-HCl/50mM NaCl
buffer (pH 7.2), and the selected DNA cleavage data are given
in Table 8. The phen complex 2 (60 𝜇M) shows moderate
“chemical nuclease” activity, and 35% conversion of the SC
(form I) to its nicked-circular form (NC, form II) of DNA is
observed. Control experiments with H
2
O
2
or the complexes
alone did not show any apparent conversion of SC to its
nicked-circular (NC) form (Figure 8).The bpy complex 3 and
bis ligand complex 1 are inactive due to their poor binding
ability to DNA. The pathways involved in the DNA cleavage
reactions are believed to be analogous to those proposed by
Sigman and coworkers for the chemical nuclease activity of
bis(phen)copper species (Scheme 1) [45, 46]. Based on the
mechanistic studies it is observed that chemical nuclease
activity is high in oxidizing condition compared to reducing
condition.
4. Conclusions
Three new Ni(II) complexes having N,S-donor ligand and
N,N-donor heterocyclic bases are prepared and character-
ized. The complex 1 was structurally characterized by X-ray
crystallography, and the structure shows the square planar
geometry. The free radical scavenging assay results showed
that complex 1 posseses significant activity when compared
to complexes 2 and 3. The biological studies showed that the
ligand and its complexes exhibited significant and different
biological activities and also the prepared compounds are
nonmutagenic. They may be potential commercial antioxi-
dants because of their nonmutagenic and nontoxic nature.
The DNA interaction of the new complexes was evaluated by
absorption, emission, andmelting temperaturemethods, and
the results suggested that the binding affinity of the complexes
increases with the presence of planar ligand in the molecule.
NiII(L)2/(LB) + DNA Ni
II(L)2
Nicked DNA
SC DNA O2
/(LB)         
MPA/H2O2
NiI/III(L)2/(LB) DNA
DNA
{OH∙}
Scheme 1: Proposed mechanistic pathway for the chemical nuclease
activity of complexes in tris-buffer medium.
Lane 3    6    2   1   4   5 7      8   9
NC
SC
Figure 8: Gel electrophoresis diagram showing the cleavage of SC
pUC19 DNA by complexes 1, 2, and 3 and ligand in 50mm tris-
HCL/50mm NaCl buffer (pH 7.2) in the presence oxidizing and
reducing agents.
The nickel(II) complexes with planar phenanthroline bases
show moderate DNA binding and cleavage ability.
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